Abstract | BACKGROUND AND PURPOSE: METHODS: Twenty-three patients with different types of intracranial "inflammatory" lesions underwent standard brain MR with and without gadolinium, followed an average of 10 days later by a ferumoxtran-10 scan. Patients were imaged 24 hours after infusion of 2.6 mg/kg ferumoxtran-10. All MR images were evaluated subjectively by 4 investigators for a difference in enhancement patterns, which could be useful in differential diagnoses. RESULTS: CONCLUSION:
|
Authors | Sándor P Manninger, Leslie L Muldoon, Gary Nesbit, Tulio Murillo, Paula M Jacobs, Edward A Neuwelt |
Journal | AJNR. American journal of neuroradiology
(AJNR Am J Neuroradiol)
Vol. 26
Issue 9
Pg. 2290-300
(Oct 2005)
ISSN: 0195-6108 [Print] United States |
PMID | 16219835
(Publication Type: Comparative Study, Journal Article, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S.)
|
Chemical References |
- Contrast Media
- Dextrans
- Magnetite Nanoparticles
- Oxides
- ferumoxtran-10
- gadodiamide
- Iron
- Gadolinium DTPA
- Ferrosoferric Oxide
|
Topics |
- Adolescent
- Adult
- Aged
- Blood-Brain Barrier
(physiopathology)
- Brain
(pathology)
- Brain Neoplasms
(diagnosis, pathology)
- Central Nervous System Diseases
(diagnosis, pathology)
- Cerebrovascular Disorders
(diagnosis, pathology)
- Contrast Media
- Demyelinating Diseases
(diagnosis, pathology)
- Dextrans
- Female
- Ferrosoferric Oxide
- Gadolinium DTPA
- Humans
- Inflammation
- Iron
- Magnetic Resonance Imaging
- Magnetite Nanoparticles
- Male
- Middle Aged
- Nanostructures
- Oxides
- Phagocytes
(pathology)
|